glutathione bdnf Targeting Microglia Via Nanotechnology: A Novel Strategy to Overcome Neuroinflammation in Major Depressive Disorder[v1] BDNF | Expert tips &
Description
Absorption Following oral administration, peak plasma concentration of alprazolam (Cmax) occurs in 1 to 2 hours post dose
![glutathione bdnf Targeting Microglia Via Nanotechnology: A Novel Strategy to Overcome Neuroinflammation in Major Depressive Disorder[v1] BDNF | Expert tips &](https://www.abcam.com/en-us/technical-resources/target-tips/media_1d4fc2201347d3eaac4591e502be32e1d9e42d1eb.jpg?width=750&format=jpg&optimize=medium)
For siRNA-mediated gene silencing, M0-human macrophages or BMDMs were transfected with 25 nM of Silencer pre-designed siRNA targeting human LIPE /HSL (143993 and 143994, Life Technologies), Lipe mouse pre-designed siRNA Set A (HY-RS18621, MCE), or a non-targeting control pool (Dharmacon, Lafayette, CO) using Lipofectamine LTX Transfection Reagent (Thermo Fisher Scientific)
![glutathione bdnf Targeting Microglia Via Nanotechnology: A Novel Strategy to Overcome Neuroinflammation in Major Depressive Disorder[v1] BDNF | Expert tips &](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00421-022-05055-6/MediaObjects/421_2022_5055_Fig7_HTML.png)
Biochimie 81, 915920
![glutathione bdnf Targeting Microglia Via Nanotechnology: A Novel Strategy to Overcome Neuroinflammation in Major Depressive Disorder[v1] BDNF | Expert tips &](https://ars.els-cdn.com/content/image/1-s2.0-S0891584918315235-fx1.jpg)
[DOI] [PubMed] [Google Scholar] 9.Mavrogenis A.F., Angelini A., Pala E., Sakellariou V.I., Ruggieri P., Papagelopoulos P.J
![glutathione bdnf Targeting Microglia Via Nanotechnology: A Novel Strategy to Overcome Neuroinflammation in Major Depressive Disorder[v1] BDNF | Expert tips &](https://www.cell.com/cms/10.1016/j.omtn.2022.05.037/asset/eb225f56-0e84-4598-8363-5b3273a31173/main.assets/fx1_lrg.jpg)